In an interview with the New York Times, Rebecca Boxer, MD, discusses how a new clinical trial will serve a population greatly in need of targeted COVID-19 treatments.
Kaiser Permanente’s clinical trials help advance treatment for health conditions and diseases ranging from heart disease and cancer to AIDS and COVID-19.
In an effort to improve understanding and clinical practice guidelines around the novel coronavirus, Kaiser Permanente’s various research centers are quickly moving to investigate potential treatment for COVID-19.
A new Kaiser Permanente study of COVID-19 patients published today as a research letter in the Journal of the American Medical Association (JAMA) provides estimates for the percentage of test-positive patients requiring hospitalization and admission to the ICU.
Brian Lim, MD, an interventional gastroenterologist with Southern California Permanente Medical Group, combines award-winning research with a compassionate approach to care inspired by his father.
Steven J. Jacobsen, MD, PhD, senior director of Research for Kaiser Permanente Southern California, was elected as president-elect of the American College of Epidemiology.
Read peer-reviewed articles in the latest edition of the Permanente Journal, including a special report containing the 40 abstracts from the annual Kaiser Permanente Los Angeles Research Week.
A risk calculator validated at Kaiser Permanente Northern California Emergency Departments may help safely avoid unnecessary CT scans in children 5 and older.
To provide the best experience, we use cookies to store and/or access device information, and to process data such as browsing behavior or unique IDs. Please click Accept to give us permission to personalize content and enable analytics. Note that opting out may adversely affect your access to certain features and functions, such as video and audio playback.
Functional
Always active
These cookies are essential for the site to function. The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.These cookies allow us to gather nonidentifiable information such as number of site visits. The technical storage or access is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
These cookies can be used to provide you with relevant advertisements, although we do not typically target users with ads. The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.